A Novel Class of Dual-Acting DCH-CORMs Counteracts Oxidative Stress-Induced Inflammation in Human Primary Tenocytes
Carbon monoxide (CO) can prevent cell and tissue damage by restoring redox homeostasis and counteracting inflammation. CO-releasing molecules (CORMs) can release a controlled amount of CO to cells and are emerging as a safer therapeutic alternative to delivery of CO in vivo. Sustained oxidative stre...
Збережено в:
Автори: | , , , , , , , , |
---|---|
Формат: | Книга |
Опубліковано: |
MDPI AG,
2021-11-01T00:00:00Z.
|
Предмети: | |
Онлайн доступ: | Connect to this object online. |
Теги: |
Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_b2ff742f5df44003bbfc475b14a2710c | ||
042 | |a dc | ||
100 | 1 | 0 | |a Federico Appetecchia |e author |
700 | 1 | 0 | |a Sara Consalvi |e author |
700 | 1 | 0 | |a Emanuela Berrino |e author |
700 | 1 | 0 | |a Marialucia Gallorini |e author |
700 | 1 | 0 | |a Arianna Granese |e author |
700 | 1 | 0 | |a Cristina Campestre |e author |
700 | 1 | 0 | |a Simone Carradori |e author |
700 | 1 | 0 | |a Mariangela Biava |e author |
700 | 1 | 0 | |a Giovanna Poce |e author |
245 | 0 | 0 | |a A Novel Class of Dual-Acting DCH-CORMs Counteracts Oxidative Stress-Induced Inflammation in Human Primary Tenocytes |
260 | |b MDPI AG, |c 2021-11-01T00:00:00Z. | ||
500 | |a 10.3390/antiox10111828 | ||
500 | |a 2076-3921 | ||
520 | |a Carbon monoxide (CO) can prevent cell and tissue damage by restoring redox homeostasis and counteracting inflammation. CO-releasing molecules (CORMs) can release a controlled amount of CO to cells and are emerging as a safer therapeutic alternative to delivery of CO in vivo. Sustained oxidative stress and inflammation can cause chronic pain and disability in tendon-related diseases, whose therapeutic management is still a challenge. In this light, we developed three small subsets of 1,5-diarylpyrrole and pyrazole dicobalt(0)hexacarbonyl (DCH)-CORMs to assess their potential use in musculoskeletal diseases. A myoglobin-based spectrophotometric assay showed that these CORMs act as slow and efficient CO-releasers. Five selected compounds were then tested on human primary-derived tenocytes before and after hydrogen peroxide stimulation to assess their efficacy in restoring cell redox homeostasis and counteracting inflammation in terms of PGE<sub>2</sub> secretion. The obtained results showed an improvement in tendon homeostasis and a cytoprotective effect, reflecting their activity as CO-releasers, and a reduction of PGE<sub>2</sub> secretion. As these compounds contain structural fragments of COX-2 selective inhibitors, we hypothesized that such a composite mechanism of action results from the combination of CO-release and COX-2 inhibition and that these compounds might have a potential role as dual-acting therapeutic agents in tendon-derived diseases. | ||
546 | |a EN | ||
690 | |a CO-releasing molecules | ||
690 | |a tenocytes | ||
690 | |a PGE<sub>2</sub> | ||
690 | |a 1,5-diarylpyrrole | ||
690 | |a 1,5-diarylpyrazole | ||
690 | |a carbon monoxide | ||
690 | |a Therapeutics. Pharmacology | ||
690 | |a RM1-950 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n Antioxidants, Vol 10, Iss 11, p 1828 (2021) | |
787 | 0 | |n https://www.mdpi.com/2076-3921/10/11/1828 | |
787 | 0 | |n https://doaj.org/toc/2076-3921 | |
856 | 4 | 1 | |u https://doaj.org/article/b2ff742f5df44003bbfc475b14a2710c |z Connect to this object online. |